Full name
ŚLĄSKI PARK TECHNOLOGII MEDYCZNYCH KARDIO-MED SILESIA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
72.11.Z - Scientific research and development activities
46.46.Z - Wholesale trade of pharmaceutical and medical products
72.19.Z - Scientific research and development activities
73.20.Z - Market research and public opinion polling
82.30.Z - Activities related to organizing fairs, exhibitions, and congresses
85.59.B - Courses and training for acquiring knowledge, skills, and professional qualifications in non-school forms
85.60.Z - Educational support activities
86.21.Z - General medical practice
86.22.Z - Specialist medical practice
86.90.C - Healthcare
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 10,3 | -2,8 | -3,2 | -15,6 |
EBITDA | 12,3 | -0,4 | -1,1 | -139,3 |
Short time liabilities | 5,8 | 2,2 | 0,9 | -59,4 |
Equity capital | 14,3 | 11,5 | 8,3 | -28,2 |
Operating profit (EBIT) | 10,5 | -2,5 | -3 | -20,3 |
Assets | 63,1 | 52,9 | 29,4 | -44,5 |
Net profit (loss) | 8,4 | -2,8 | -3,2 | -15,6 |
Cash | 14,5 | 12,3 | 4,8 | -60,9 |
Net income from sale | 25,4 | 8,5 | 3,8 | -55,3 |
Liabilities and provisions for liabilities | 48,8 | 41,4 | 21,1 | -49 |
Working assets | 49,8 | 39,4 | 17,4 | -55,7 |
Depreciation | 1,8 | 2,1 | 1,9 | -5,8 |
% | % | % | p.p. | |
Profitability of capital | 59,1 | -24,4 | -39,2 | -14,8 |
Equity capital to total assets | 22,6 | 21,7 | 28,1 | 6,4 |
Gross profit margin | 40,4 | -33 | -85,4 | -52,4 |
EBITDA Margin | 48,5 | -5,3 | -28,4 | -23,1 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 83 | 93 | 84 | -9 |
Current financial liquidity indicator | 1.1361501216888428 | 1.0691548585891724 | 1.0254086256027222 | -0,1 |
Net dept to EBITDA | -0.755145788192749 | 16.832544326782227 | 0.4635363817214966 | -16,3 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane